COMPANY
LENZ Therapeutics
FDA-approved therapeutic company
Timeline
- FDA FDA New drug/biologic (novel): VIZZ (aceclidine hydrochloride) — NDA218585, Jul 31, 2025. Applicant at approval: LENZ Therapeutics, Inc. source ↗
FDA records (last 2 years)
- FDA New drug/biologic (novel): VIZZ (aceclidine hydrochloride) — NDA218585, Jul 31, 2025. Applicant at approval: LENZ Therapeutics, Inc. source ↗
Connect
See your connections at LENZ Therapeutics on LinkedIn (search by name, results not checked)